Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NPY4R | P50391 | 8/20 | 0.34 |
| ▸ | NPY1R | P25929 | 5/20 | 0.34 |
| ▸ | NPY2R | P49146 | 3/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1551710 | 1.00 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Acetic Acid SCHEMBL160844 | 1.00 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL17769024 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL162756 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL93473 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL93472 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Acetic Acid SCHEMBL4407896 | 0.95 | FOLH1 (0.44) | FOLH1ALOX15MEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1578565 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Hydrochloric Acid SCHEMBL974818 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Hydrochloric Acid SCHEMBL7367067 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6864086-B2 | Nitric oxide-scavenging system for culturing oocytes, embryos, or other cells | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2005-03-08 | — | — | US | claimed |
| US-20150148317-A1 | SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | INVIVO THERAPEUTICS CORPORATION (US) | 2015-05-28 | — | — | US | disclosed |
| US-20130324500-A1 | SPINAL CORD INJURY, INFLAMMATION AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | INVIVO THERAPEUTICS CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| US-20130324509-A1 | SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | INVIVO THERAPEUTICS CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| EP-2346515-A1 | SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | Invivo Therapeutics Corporation (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20100196481-A1 | SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | INVIVO THERAPEUTICS CORPORATION (US) | 2010-08-05 | — | — | US | disclosed |
| WO-2010036961-A1 | SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS | INVIVO THERAPEUTICS CORPORATION (US) | 2010-04-01 | — | — | WO | disclosed |
| US-20090220968-A1 | Methods and Apparatus for Near Field Irradiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-09-03 | — | — | US | disclosed |
| EP-1996320-A2 | METHODS AND APPARATUS FOR NEAR FIELD IRRADIATION | The President and Fellows of Harvard College (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007106402-A2 | METHODS AND APPARATUS FOR NEAR FIELD IRRADIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-09-20 | — | — | WO | disclosed |
| US-6864086-B2 | Nitric oxide-scavenging system for culturing oocytes, embryos, or other cells | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2005-03-08 | — | — | US | disclosed |
| US-20030068816-A1 | Nitric oxide-scavenging system for culturing oocytes, embryos, or other cells | HANSEL WILLIAM (US) | 2003-04-10 | — | — | US | disclosed |
| US-6426219-B2 | CULTURE CONTAINS A NITRIC OXIDE INHIBITOR SUCH AS FREE HEMOGLOBIN | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2002-07-30 | — | — | US | disclosed |
| US-20010034060-A1 | Nitric oxide-scavenging system for culturing oocytes, embryos, or other cells | HANSEL WILLIAM (US) | 2001-10-25 | — | — | US | disclosed |
| US-6255109-B1 | CULTURING MAMMALIAN OOCYTES OR EMBRYOS IN A CO-CULTURE SYSTEM IN THE PRESENCE OF HEMOGLOBIN, A NITRIC OXIDE INHIBITOR; PROMOTING THE MAINTENANCE, GROWTH AND DEVELOPMENT OF CELLS AND ELIMINATES TOXIC EFFECTS OF NITRIC OXIDE | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2001-07-03 | — | — | US | disclosed |